Similar articles

• Low predictive value of cyclosporine level for efficacy or renal dysfunction in psoriasis and idiopathic nephrotic syndrome.

  Feutren G, Miller C. Feutren G, et al. Transplant Proc. 1990 Jun;22(3):1299-302. Transplant Proc. 1990. PMID: 2349691 No abstract available.
• Factors predictive of cyclosporine-induced nephrotoxicity: the role of cyclosporine blood levels.

  Bach JF, Feutren G, Noel LH, Hannedouche T, Landais P, Timsit J, Boitard C, Bougnères P, Boitard C, Grünfeld JP, et al. Bach JF, et al. Transplant Proc. 1990 Jun;22(3):1296-8. Transplant Proc. 1990. PMID: 2349690 No abstract available.
• Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.

  Shaw LM, Audet PR, Grossman RA, Fields L, Lensmeyer GL, Dafoe DC. Shaw LM, et al. Transplant Proc. 1990 Jun;22(3):1267-73. Transplant Proc. 1990. PMID: 2349688 No abstract available.
• Pharmacokinetic and pharmacodynamic studies of cyclosporine in bone marrow transplantation.

  Yee GC. Yee GC. Transplant Proc. 1990 Jun;22(3):1327-30. Transplant Proc. 1990. PMID: 2190394 Review. No abstract available.
• Effects of cyclosporine on renal function in psoriasis patients.

  Messana JM, Rocher LL, Ellis CN, Fradin MS, VanGurp JR, Cantu-Gonzalez G, Parish TG, Wheeler SM, Voorhees JJ. Messana JM, et al. J Am Acad Dermatol. 1990 Dec;23(6 Pt 2):1288-91; discussion 1291-3. doi: 10.1016/0190-9622(90)70356-m. J Am Acad Dermatol. 1990. PMID: 2277137 Review.